Due to inclement weather, the University of Cincinnati campus will close from 7 a.m. Dec. 2, 2025, until 7 a.m. on Dec. 3, 2025.

Graduate Admissions

Graduate Students seated at tables

The College of Arts and Sciences at the University of Cincinnati offers 22 Master’s, 15 doctoral programs, and 11 graduate certificates, enrolling over 1,000 students. Seventeen majors also offer a 4+1 option, allowing undergraduates to earn both a Bachelor’s and Master’s degree in five years. Programs are customizable, with options like Chemistry (biochemistry to computational chemistry) and Sociology (research in hospitals and government). Last year, A&S researchers secured nearly $11 million in external funding, providing a dynamic, hands-on learning environment.

Alumni

As a proud alum of the University of Cincinnati’s College of Arts and Sciences, you already know the value of a UC education. Now, take the next step with one of our 22 Master’s programs, 15 doctoral degrees, or 11 graduate certificates.

Whether you're looking to deepen your expertise, pivot to a new field, or enhance your career, our flexible and rigorous graduate programs offer the tools to help you succeed. With opportunities for interdisciplinary study, real-world research experience, and a vibrant academic community, there’s no better place to continue your journey than right here at UC.

1

Glomerular disease treatment guidelines updated

December 1, 2025

Given the rapidly growing evidence base in glomerular disease, the Kidney Disease Improving Global Outcomes group, known as KDIGO, recently published an updated clinical practice guideline for the management of immunoglobulin A nephropathy (IgAN) and immunoglobulin A vasculitis (IgAV). University of Cincinnati nephrologists recently shared what's new and what's next with MedCentral.

2

UC to lead study on extended use of drug in ACL reconstructions

December 1, 2025

The University of Cincinnati will lead a national study that could have a major effect on how people, especially teens, recover from ACL surgery. It will soon begin enrolling patients in a clinical trial. The study will look at the effectiveness of using a surgical drug post-operatively to speed up recovery. Tranexamic acid (TXA) is already regularly used during surgeries to limit bleeding.